Clinical Roundup Researchers find cell markers to track TNBC, Baylor College of Medicine study finds January 23, 2026Vol.52 No.03
Clinical Roundup Sylvester-led study focuses on rate of failure in head and neck cancer trials January 23, 2026Vol.52 No.03
Clinical Roundup Researchers develop tool that can identify high- and low-risk metastatic prostate cancer patients earlier January 23, 2026Vol.52 No.03
Clinical Roundup Researchers identify ideal duration of prostate cancer hormone therapy January 23, 2026Vol.52 No.03
Drugs & Targets FDA issues draft guidance on MRD and CR as primary endpoints in MM drug trials to support accelerated approval January 23, 2026Vol.52 No.03
Drugs & Targets Personalis Real-Time Variant Tracker identifies resistance mutations across several hundred clinically relevant hotspots January 23, 2026Vol.52 No.03
News Analysis ACS report trumpets 70% five-year survival for all cancers amid uncertain funding outlook January 16, 2026Vol.52 No.02By Jacquelyn Cobb and Paul Goldberg
Health Equity New Medicaid work requirements could lead to 1.6 million missed cancer screenings over two years January 16, 2026Vol.52 No.02By Sara Willa Ernst
Trials & Tribulations A radiation oncologist’s perspective: Why we need to accelerate early detection strategies for lung cancers January 16, 2026Vol.52 No.02By Kevin King
Cancer Policy FDA releases 10 guiding principles for AI use in drug development January 16, 2026Vol.52 No.02By Sara Willa Ernst
